![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 14, 9238-9245, April 2, 1999
i2, G
i3, and
G
in Modulation of Forskolin- or Gs-mediated cAMP
Accumulation and Calcium Mobilization by Dopamine D2S Receptors
,
, and
From the Previous studies have shown that a single G
protein-coupled receptor can regulate different effector systems by
signaling through multiple subtypes of heterotrimeric G proteins.
In LD2S fibroblast cells, the dopamine D2S receptor couples to
pertussis toxin (PTX)-sensitive Gi/Go
proteins to inhibit forskolin- or prostaglandin
E1-stimulated cAMP production and to stimulate calcium mobilization. To analyze the role of distinct G
Department of Pharmacology and Therapeutics,
McGill University, Montreal H3G 1Y6, Canada and the ¶ Neuroscience
Research Institute, University of Ottawa, Ottawa K1H 8M5, Canada
i/o
protein subtypes, LD2S cells were stably transfected with a series of
PTX-insensitive G
i/o protein Cys
Ser point mutants
and assayed for D2S receptor signaling after PTX treatment. The level
of expression of the transfected G
mutant subunits was similar to
the endogenous level of the most abundant G
i/o proteins
(G
o, G
i3). D2S receptor-mediated inhibition of forskolin-stimulated cAMP production was retained only in
clones expressing mutant G
i2. In contrast, the D2S
receptor utilized G
i3 to inhibit
PGE1-induced (Gs-coupled) enhancement of cAMP
production. Following stable or transient transfection, no single or
pair set of mutant G
i/o subtypes rescued the
D2S-mediated calcium response following PTX pretreatment. On the other
hand, in LD2S cells stably transfected with GRK-CT, a receptor kinase fragment that specifically antagonizes G
subunit activity, D2S receptor-mediated calcium mobilization was blocked. The observed specificity of G
i2 and G
i3 for different
states of adenylyl cyclase activation suggests a higher level of
specificity for interaction of G
i subunits with
forskolin- versus Gs-activated states of
adenylyl cyclase than has been previously appreciated.
This article has been cited by other articles:
![]() |
J. R. Lane, B. Powney, A. Wise, S. Rees, and G. Milligan G Protein Coupling and Ligand Selectivity of the D2L and D3 Dopamine Receptors J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 319 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rogaeva, X.-M. Ou, H. Jafar-Nejad, S. Lemonde, and P. R. Albert Differential Repression by Freud-1/CC2D1A at a Polymorphic Site in the Dopamine-D2 Receptor Gene J. Biol. Chem., July 20, 2007; 282(29): 20897 - 20905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lane, B. Powney, A. Wise, S. Rees, and G. Milligan Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3 Mol. Pharmacol., May 1, 2007; 71(5): 1349 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mao, Q. Zhao, M. Daigle, M. H. Ghahremani, P. Chidiac, and P. R. Albert RGS17/RGSZ2, a Novel Regulator of Gi/o, Gz, and Gq Signaling J. Biol. Chem., June 18, 2004; 279(25): 26314 - 26322. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Senogles, T. L. Heimert, E. R. Odife, and M. W. Quasney A Region of the Third Intracellular Loop of the Short Form of the D2 Dopamine Receptor Dictates Gi Coupling Specificity J. Biol. Chem., January 16, 2004; 279(3): 1601 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Cabrera-Vera, J. Vanhauwe, T. O. Thomas, M. Medkova, A. Preininger, M. R. Mazzoni, and H. E. Hamm Insights into G Protein Structure, Function, and Regulation Endocr. Rev., December 1, 2003; 24(6): 765 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Ou, S. Lemonde, H. Jafar-Nejad, C. D. Bown, A. Goto, A. Rogaeva, and P. R. Albert Freud-1: A Neuronal Calcium-Regulated Repressor of the 5-HT1A Receptor Gene J. Neurosci., August 13, 2003; 23(19): 7415 - 7425. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, M. H. Ghahremani, B. Banihashemi, and P. R. Albert Diacylglycerol and ceramide formation induced by dopamine D2S receptors via Gbeta gamma -subunits in Balb/c-3T3 cells Am J Physiol Cell Physiol, March 1, 2003; 284(3): C640 - C648. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, L. Robillard, B. Banihashemi, and P. R. Albert Growth Hormone-induced Diacylglycerol and Ceramide Formation via Galpha i3 and Gbeta gamma in GH4 Pituitary Cells. POTENTIATION BY DOPAMINE-D2 RECEPTOR ACTIVATION J. Biol. Chem., December 6, 2002; 277(50): 48427 - 48433. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Banihashemi and P. R. Albert Dopamine-D2S Receptor Inhibition of Calcium Influx, Adenylyl Cyclase, and Mitogen-Activated Protein Kinase in Pituitary Cells: Distinct G{alpha} and G{beta}{gamma} Requirements Mol. Endocrinol., October 1, 2002; 16(10): 2393 - 2404. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Albert G Protein Preferences for Dopamine D2 Inhibition of Prolactin Secretion and DNA Synthesis in GH4 Pituitary Cells Mol. Endocrinol., August 1, 2002; 16(8): 1903 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Albert Editorial: Dopamine-D2-Mediated Inhibition of TRH-Induced PLC Activation in Pituitary Cells--Direct or Indirect? Endocrinology, March 1, 2002; 143(3): 744 - 746. [Full Text] [PDF] |
||||
![]() |
K. L. J. Evans, J. D. Cropper, K. A. Berg, and W. P. Clarke Mechanisms of Regulation of Agonist Efficacy at the 5-HT1A Receptor by Phospholipid-Derived Signaling Components J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1025 - 1035. [Abstract] [Full Text] |
||||
![]() |
P. J. Pauwels, F. Finana, S. Tardif, T. Wurch, and F. C. Colpaert Dynamic Dopamine-Antagonist Interactions at Recombinant Human Dopamine D2short Receptor: Dopamine-Bound versus Antagonist-Bound Receptor States J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 133 - 140. [Abstract] [Full Text] |
||||
![]() |
B. Y. Ho, A. Stadnicka, P. L. Prather, A. R. Buckley, L. L. Current, Z. J. Bosnjak, and W.-M. Kwok Cannabinoid CB1 Receptor-Mediated Inhibition of Prolactin Release and Signaling Mechanisms in GH4C1 Cells Endocrinology, May 1, 2000; 141(5): 1675 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Ghahremani, C. Forget, and P. R. Albert Distinct Roles for Galpha i2 and Gbeta gamma in Signaling to DNA Synthesis and Galpha i3 in Cellular Transformation by Dopamine D2S Receptor Activation in BALB/c 3T3 Cells Mol. Cell. Biol., March 1, 2000; 20(5): 1497 - 1506. [Abstract] [Full Text] |
||||
![]() |
P. R. Albert, N. Sajedi, S. Lemonde, and M. H. Ghahremani Constitutive Gi2-dependent Activation of Adenylyl Cyclase Type II by the 5-HT1A Receptor. INHIBITION BY ANXIOLYTIC PARTIAL AGONISTS J. Biol. Chem., December 10, 1999; 274(50): 35469 - 35474. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. F. Liu, M. H. Ghahremani, M. M. Rasenick, K. H. Jakobs, and P. R. Albert Stimulation of cAMP Synthesis by Gi-coupled Receptors upon Ablation of Distinct Galpha i Protein Expression. Gi SUBTYPE SPECIFICITY OF THE 5-HT1A RECEPTOR J. Biol. Chem., June 4, 1999; 274(23): 16444 - 16450. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Ou, J. M. Storring, N. Kushwaha, and P. R. Albert Heterodimerization of Mineralocorticoid and Glucocorticoid Receptors at a Novel Negative Response Element of the 5-HT1A Receptor Gene J. Biol. Chem., April 20, 2001; 276(17): 14299 - 14307. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cordeaux, S. A. Nickolls, L. A. Flood, S. G. Graber, and P. G. Strange Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction. EVIDENCE FOR AGONIST SELECTION OF G PROTEIN SUBTYPE J. Biol. Chem., July 27, 2001; 276(31): 28667 - 28675. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Leaney and A. Tinker The role of members of the pertussis toxin-sensitive family of G proteins in coupling receptors to the activation of the G protein-gated inwardly rectifying potassium channel PNAS, May 9, 2000; 97(10): 5651 - 5656. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |